Corroborating previous documentation, our results confirmed through gain- and loss- of function assays that lncRNA UCA1 inhibited the expression of SOCS3, thereby enhancing the malignant phenotypes, tumorigenesis and Gem resistance of pancreatic cancer cells. This evidence concerns the gene UCA1 and pancreatic neoplasm.